Bolus administration of cladribine in the treatment of Waldenstrom macroglobulinaemia

British Journal of Haematology

Volumn 103, Issue 3, 1998, Pages 690-695

  Liu, Eva S ^a   Burian, Carol ^a   Miller, William E ^a   Saven, Alan ^a  

^a SCRIPPS CLINIC   (United States)

Author keywords

Bolus cladribine; Waldenstrom macroglobulinaemia

Indexed keywords

CARMUSTINE; CHLORAMBUCIL; CLADRIBINE; CYCLOPHOSPHAMIDE; DOXORUBICIN; FLUDARABINE; IMMUNOGLOBULIN M; INTERFERON; MELPHALAN; PREDNISONE; VINCRISTINE;

ADULT; AGED; ARTICLE; BOLUS INJECTION; BONE MARROW SUPPRESSION; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG RESPONSE; FEMALE; HERPES ZOSTER; HUMAN; INTRAVENOUS DRUG ADMINISTRATION; MALE; NEUTROPENIA; PHASE 2 CLINICAL TRIAL; PRIORITY JOURNAL; SKIN CANCER; SURVIVAL; WALDENSTROEM MACROGLOBULINEMIA;

ADULT; AGED; AGED, 80 AND OVER; ANTINEOPLASTIC AGENTS; CLADRIBINE; HUMANS; INFUSIONS, INTRAVENOUS; MIDDLE AGED; RECURRENCE; SURVIVAL ANALYSIS; WALDENSTROM MACROGLOBULINEMIA;

EID: 0031788917     PISSN: 00071048     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2141.1998.01069.x     Document Type: Article

References (31)

1. Carrera, C.J., Piro, L.D., Miller, W.E., Carson, D.A. & Beutler, E. (1987) Remission induction in hairy cell leukemia by treatment with 2-chlorodeoxyadenosine: role of DNA strand breaks and NAD depletion. (Abstract). Clinical Research, 35, 597A.
2. Carrera, C.J., Piro, L.D., Saven, A., Cox, K., Beutler, E., Carson, D.A. & Kipps, T.J. (1990) Restoration of lymphocyte subsets following 2-chlorodeoxyadenosine remission induction in hairy cell leukemia. (Abstract). Blood, 76, (Suppl. 1), 260a.
3. Carson, D.A., Wasson, D.B. & Beutler, E. (1984) Antileukemic and immunosuppressive activity of 2-chloro-2′-deoxyadenosine. Proceedings of the National Academy of Sciences of the United States of America, 81, 2232-2236.
4. Claman, G.H., Corder, R.T. & Burns, C.P. (1980) Successful doxorubicin therapy of primary macroglobulinemia resistant to alkylating agents. American Journal of Hematology, 9, 221-223.
5. Delannoy, A., Ferrant, A., Martiat, P., Bosly, A., Zenebergh, A. & Michaux, J.L. (1994) 2-Chlorodeoxyadenosine therapy in Waldenström's macroglobulínaemía. Nouvelle Revue Française: D, Hématologie, 36, 317-320.
6. Dhodapkar, M., Jacobsen, J., Gertz, M., Crowley, J., Shurafa, M., Salamon, S., Kyle, R. & Barlogie, B. (1997) Phase II intergroup trial of fludarabine (FAMP) in Waldenström's macroglobulinemia (WM): results of Southwest Oncology Group trial (SWOG 9003) in 220 patients. (Abstract). Blood, 90, (Suppl. 1), 2571.
7. Dimopoulos, M. & Alexanian, R. (1994) Waldenström's macroglobulinemia. Blood, 83, 1452-1459.
8. Dimopoulos, M.A., Kantarjian, H.M., Estey, E.H., O'Brien, S., Delasalle, K., Keating, M.J., Freireich, E.J. & Alexanian, R. (1993a) Treatment of Waldenström macroglobulinemia with 2-chlorodeoxyadenosine. Annals of Internal Medicine, 118, 195-198.
9. Dimopoulos, M.A., Kantarjian, H., Weber, D., O'Brien, S., Estey, E., Delasalle, K., Rose, E., Cabanillas, F., Keating, M. & Alexanian, R. (1994a) Primary therapy of Waldenstrom's macroglobulinemia with 2-chlorodeoxyadenosine. Journal of Clinical Oncology, 12, 2694-2698.
10. Dimopoulos, M.A., O'Brien, S., Kantarjian, H., Pierce, S., Delasalle, K., Barlogie, B., Alexanian, R. & Keating, M.J. (1993b) Fludarabine therapy in Waldenstrom's macroglobulinemia. American Journal of Medicine, 95, 49-52.
11. Dimopoulos, M.A., Weber, D., Delasalle, K.B., Keating, M. & Alexanian, R. (1995) Treatment of Waldenstrom's macroglobulinemia resistant to standard therapy with 2-chlorodeoxyadenosine: identification of prognostic factors. Annals of Oncology, 6, 49-52.
12. Dimopoulos, M.A., Weber, D.M., Kantarjian, H., Keating, M. & Alexanian, R. (1994b) 2-Chlorodeoxyadenosine therapy of patients with Waldenstrom's macroglobulinemia previously treated with fludarabine. Annals of Oncology, 5, 288-289.
13. Jane, S.M. & Salem, H.H. (1988) Treatment of resistant Waldenström's macroglobulinemia with high-dose glucocorticosteroids. Australia and New Zealand Journal of Medicine, 18, 77-78.
14. Juliusson, G., Lenkei, R. & Liliemark, J. (1994) Flow cytometry of blood and bone marrow cells from patients with hairy cell leukemia: phenotype of hairy cells and lymphocyte subsets after treatment with 2-chlorodeoxyadenosine. Blood, 83, 3672-3681.
15. Kantarjian, H.M., Alexanian, R., Koller, C., Kurzrock, R. & Keating, M.J. (1990) Fludarabine therapy in macroglobulinemic lymphomas. Blood, 75, 1928-1931.
16. Kay, A.C., Saven, A., Carrera, C.J., Carson, D.A., Beutler, E. & Piro, L.D. (1992) 2-Chlorodeoxyadenosine treatment of low-grade lymphomas. Journal of Clinical Oncology, 10, 371-377.
17. Liliemark, J., Albertioni, F., Hassan, M., Pettersson, B. & Juliusson, G. (1992) On the bioavailability of oral and subcutaneous 2-chloro2′-deoxyadenosine in humans: alternative routes of administration. Journal of Clinical Oncology, 10, 1514-1518.
18. Liliemark, J., Pettersson, B. & Juliusson, G. (1991) The relationship between plasma 2′-chloro-2′-deoxyadenosine (CdA) and cellular CdA nucleotides (CdAN) after intermittent and continuous IV infusion in patients with chronic lymphocytic leukemia. (Abstract). Blood, 78, 123.
19. MacKenzie, M.R. & Fudenberg, H.H. (1972) Macroglobulinemia: an analysis of 40 patients. Blood, 39, 874-889.
20. Oken, M.M., Creech, R.H., Tormey, D.C., Horton, J., Davis, T.E., McFadden, E.T. & Carbone, P.P. (1982) Toxicity and response criteria of the Eastern Cooperative Oncology Group. American Journal of Clinical Oncology, 5, 649-655.
21. Petrucci, M.D., Avvisati, G., Tribalto, M., Giovangrossi, P. & Mandelli, F. (1989) Waldenstrom's macroglobulinemia: results of a combined oral treatment in 34 newly diagnosed patients. Journal of Internal Medicine, 226, 443-447.
22. Piro, L.D., Carrera, C.J., Carson, D.A. & Beutler, E. (1990) Lasting remissions in hairy cell leukemia induced by a single infusion of 2-chlorodeoxyadenosine. New England Journal of Medicine, 322, 1117-1121.
23. Quesada, J.R., Alexanian, R., Kurzrock, R., Barlogie, B., Saks, S. & Gutterman, J.U. (1988) Recombinant interferon gamma in hairy cell leukemia, multiple myeloma, and Waldenstrom's macroglobulinemia. American Journal of Hematoloay, 29, 1-4.
24. Saven, A., Carrera, C.J., Carson, D.A., Beutler, E. & Piro, L.D. (1991) 2-Chlorodeoxyadenosine treatment of refractory chronic lymphocytic leukemia. Leukemia and Lymphoma, 5, (Suppl.), 133-138.
25. Saven, A., Cheung, W.K., Smith, I., Moyer, M., Johannsen, T., Rose, E., Gollard, R., Kosty, M., Miller, W.E. & Piro, L.D. (1996a) Pharmacokinetic study of oral and bolus intravenous 2-chlorodeoxyadenosine in patients with malignancy. Journal of Clinical Oncology, 14, 978-983.
26. Saven, A., Lee, T., Kosty, M. & Piro, L. (1996b) Cladribine and mitoxantrone dose escalation in indolent non-Hodgkin's lymphoma. Journal of Clinical Oncology, 14, 2139-2144.
27. Saven, A. & Piro, L.D. (1994) 2-Chlorodeoxyadenosine: a newer purine analogue active in the treatment of indolent lymphoid malignancies. Annals of Internal Medicine, 120, 784-791.
28. Saven, A. & Piro, L.D. (1997) 2-Chlorodeoxyadenosine treatment of lymphoma. Advances in Lymphoma Research (ed. by F. Canbanillas and M. A. Rodriguez), p. 15. Kluwer Academic Publishers, Boston.
29. + lymphocyte counts in patients with hairy cell leukemia. Blood, 83, 2906-2911.
30. Weber, D.M., Delasalle, K., Gavino, M., Wood, A., Cabanillas, F. & Alexanian, R. (1997) Primary treatment of Waldenström's macroglobulinemia (WM) with subcutaneous 2-chlorodeoxyadenosine (2-CdA) and oral cyclophosphamide. (Abstract). Blood, 90, (Suppl. 1), 1592.
31. Zinzani, P.L., Gherlinzoni, F., Bendandi, M., Zaccaria, A., Aitini, E., Salvucci, M. & Tura, S. (1995) Fludarabine treatment in resistant Waldenstrom's macroglobulinaemia. European Journal of Haematology, 54, 120-123.